 |
|
CHEMICAL BLOCKADE OF THE SYMPATHETIC NERVOUS SYSTEM IN ESSENTIAL HYPERTENSIONExperience with Oral Therapy with 688-A (N-Phenoxyisopropyl-N-Benzyl-βChloroethylamine Hydrochloride)
MARVIN MOSER, M.D.;
MAX WALTERS, M.D.;
ARTHUR M. MASTER, M.D.;
ROBERT C. TAYMOR, M.D.;
JEAN METRAUX, M.D.
AMA Arch Intern Med. 1952;89(5):708-723.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
THE EXACT nature of essential hypertension has not been clearly established, and, as a result, many drugs, diets, and operative procedures have been used in the treatment of this disease. In most instances therapy has either proved more annoying to the patient than the disease itself or produced variable results. The numerous theories regarding the etiological basis of essential hypertension have been summarized repeatedly by many authors,1 but at present most observers agree that there are probably both neurogenic and humoral factors that produce and maintain blood pressure in certain persons at a hypertensive level. A great deal of the treatment has been aimed at controlling or eliminating the neurogenic factor, for the exact humoral mechanism that operates in hypertension has still not been clarified. Other drugs have been used because of their direct action upon the vascular system.
Therapy with thiocyanate derivatives has been employed for years, and
. . . [Full Text PDF of this Article]
Author Affiliations
NEW YORK
From the Cardiographic Department, The Mount Sinai Hospital.
Footnotes
Dr. Moser is Trainee in Cardiology, The National Heart Institute.
The 688-A ("dibenzyline") used in this study was supplied by Smith, Kline & French Laboratories, Philadelphia 1.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
